Joseph Todisco, Chief Executive Officer at CorMedix Inc. (CRMD), sold 30,000 shares at $12.00 ($360K) on 2025-12-18, disclosed to the SEC on 2025-12-19.
Scheduled sale ($360k) by Chief Executive Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| CRMD | BUY | 2023-09-08 | $37K | — | Filing → |
| CRMD | BUY | 2022-11-16 | $76K | — | Filing → |
| CRMD | BUY | 2022-08-25 | $18K | — | Filing → |